[Editorial Comment.--Celerina, Aletris Cordial and Kennedy’s Pinus Canadensis, Light and Dark, appear to be the entire output of the Rio Chemical Company, which was one of the earliest of the various companies organized by James J. Lawrence of _Medical Brief_ fame. The business was moved from St. Louis to New York City in 1901. According to what we believe to be reliable information, the Rio Chemical Company is now composed of James P. Dawson, president; William W. Conley, vice-president and treasurer; and E. D. Pinkerton, secretary. These also constitute the directors. It appears that James P. Dawson is a member of the law firm of Dawson and Garven, St. Louis; E. D. Pinkerton is said to be Miss Effie D. Pinkerton, stenographer for Dawson and Garven. We know little concerning William W. Conley except that he appears to be in charge of the establishment in New York. We find no evidence that he is either a chemist or a pharmacist; his name does not appear in the membership list of the American Chemical Society or of the American Pharmaceutical Association, nor can we discover that he has published anything in the way of chemistry or pharmacy. As a matter of fact, the Rio Chemical Company is another of the pseudo-chemical companies created to exploit one or more proprietaries--in this instance Celerina, Aletris Cordial and Pinus Canadensis. The following medical journals carry advertisements of the Rio products (or did late in 1914): _American Journal of Surgery_, _American Medicine_, _Denver Medical Times and Utah Medical Journal_, _Eclectic Medical Journal_, _International Journal of Surgery_, _Interstate Medical Journal_, _Massachusetts Medical Journal_, _Medical Brief_, _Medical Century_, Medical Council, _Medical Review of Reviews_, _Medical Sentinel_, _Medical Standard_, _Texas Medical Journal_ and _Woman’s Medical Journal_.].--(_From The Journal A. M. A., Feb. 13, 1915._) CINERARIA MARITIMA Report of the Council on Pharmacy and Chemistry Occasional inquiries in regard to the therapeutic value of _Cineraria maritima_ caused the Council to consider the drug with reference to its fitness for inclusion in N. N. R. among non-official, non-proprietary remedies. The following report, having been submitted to the Council by a subcommittee, was adopted and its publication authorized. W. A. Puckner, Secretary. _To the Council_:--The juice of a plant referred to as _Cineraria maritima_ was at one time supposed to be of value in the treatment of cataract and certain other affections of the eye. No scientific evidence is available to show that the drug is therapeutically active, and its value is no doubt correctly estimated by Dr. Casey Wood, who (“Ophthalmic Therapeutics,” p. 446; Cleveland Press, Chicago, 1909) says: